Your browser doesn't support javascript.
loading
A novel approach for preparation of the antisera reagent for potency determination of inactivated H7N9 influenza vaccines.
Schmeisser, Falko; Jing, Xianghong; Joshi, Manju; Vasudevan, Anupama; Soto, Jackeline; Li, Xing; Choudhary, Anil; Baichoo, Noel; Resnick, Josephine; Ye, Zhiping; McCormick, William; Weir, Jerry P.
Affiliation
  • Schmeisser F; Laboratory of DNA Viruses, Division of Viral Products, Center for Biologics Evaluations and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Jing X; Laboratory of Respiratory Viral Diseases, Division of Viral Products, Center for Biologics Evaluations and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Joshi M; Division of Biological Standards and Quality Control, Center for Biologics Evaluations and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Vasudevan A; Laboratory of DNA Viruses, Division of Viral Products, Center for Biologics Evaluations and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Soto J; Laboratory of Respiratory Viral Diseases, Division of Viral Products, Center for Biologics Evaluations and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Li X; Laboratory of Respiratory Viral Diseases, Division of Viral Products, Center for Biologics Evaluations and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Choudhary A; Division of Biological Standards and Quality Control, Center for Biologics Evaluations and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Baichoo N; Division of Biological Standards and Quality Control, Center for Biologics Evaluations and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Resnick J; Division of Biological Standards and Quality Control, Center for Biologics Evaluations and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Ye Z; Laboratory of Respiratory Viral Diseases, Division of Viral Products, Center for Biologics Evaluations and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • McCormick W; Division of Biological Standards and Quality Control, Center for Biologics Evaluations and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Weir JP; Laboratory of DNA Viruses, Division of Viral Products, Center for Biologics Evaluations and Research, Food and Drug Administration, Silver Spring, MD, USA.
Influenza Other Respir Viruses ; 10(2): 134-40, 2016 Mar.
Article in En | MEDLINE | ID: mdl-26616263
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza Vaccines / Vaccines, Inactivated / Influenza A Virus, H7N9 Subtype / Vaccine Potency / Immune Sera / Antibodies, Viral Limits: Animals / Humans Country/Region as subject: Asia Language: En Journal: Influenza Other Respir Viruses Journal subject: VIROLOGIA Year: 2016 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Influenza Vaccines / Vaccines, Inactivated / Influenza A Virus, H7N9 Subtype / Vaccine Potency / Immune Sera / Antibodies, Viral Limits: Animals / Humans Country/Region as subject: Asia Language: En Journal: Influenza Other Respir Viruses Journal subject: VIROLOGIA Year: 2016 Document type: Article Affiliation country: Country of publication: